232 related articles for article (PubMed ID: 36741271)
1. Candidiasis and Other Emerging Yeasts.
Sharma M; Chakrabarti A
Curr Fungal Infect Rep; 2023; 17(1):15-24. PubMed ID: 36741271
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for non-albicans Candida and uncommon yeast isolates.
Teke L; Barış A; Bayraktar B
J Microbiol Methods; 2021 Jun; 185():106232. PubMed ID: 33961963
[TBL] [Abstract][Full Text] [Related]
4. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry.
Aslani N; Janbabaei G; Abastabar M; Meis JF; Babaeian M; Khodavaisy S; Boekhout T; Badali H
BMC Infect Dis; 2018 Jan; 18(1):24. PubMed ID: 29310582
[TBL] [Abstract][Full Text] [Related]
5. Investigating Antifungal Susceptibility in
Delavy M; Dos Santos AR; Heiman CM; Coste AT
Front Cell Infect Microbiol; 2019; 9():19. PubMed ID: 30792970
[TBL] [Abstract][Full Text] [Related]
6. Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays.
Pote ST; Sonawane MS; Rahi P; Shah SR; Shouche YS; Patole MS; Thakar MR; Sharma R
Infect Drug Resist; 2020; 13():1133-1145. PubMed ID: 32368104
[TBL] [Abstract][Full Text] [Related]
7. Candida auris: Epidemiology, biology, antifungal resistance, and virulence.
Du H; Bing J; Hu T; Ennis CL; Nobile CJ; Huang G
PLoS Pathog; 2020 Oct; 16(10):e1008921. PubMed ID: 33091071
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom.
Borman AM; Muller J; Walsh-Quantick J; Szekely A; Patterson Z; Palmer MD; Fraser M; Johnson EM
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182537
[TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology, Antifungal Susceptibility, and Virulence Evaluation of
Chen J; Hu N; Xu H; Liu Q; Yu X; Zhang Y; Huang Y; Tan J; Huang X; Zeng L
Front Cell Infect Microbiol; 2021; 11():721439. PubMed ID: 34604110
[TBL] [Abstract][Full Text] [Related]
10. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris.
Quindós G; Marcos-Arias C; San-Millán R; Mateo E; Eraso E
Int Microbiol; 2018 Sep; 21(3):107-119. PubMed ID: 30810955
[TBL] [Abstract][Full Text] [Related]
11. Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia.
Seyoum E; Bitew A; Mihret A
BMC Infect Dis; 2020 Mar; 20(1):231. PubMed ID: 32188422
[TBL] [Abstract][Full Text] [Related]
12. Candida khanbhai sp. nov., a new clinically relevant yeast within the Candida haemulonii species complex.
de Jong AW; Al-Obaid K; Mohd Tap R; Gerrits van den Ende B; Groenewald M; Joseph L; Ahmad S; Hagen F
Med Mycol; 2023 Feb; 61(2):. PubMed ID: 36694950
[TBL] [Abstract][Full Text] [Related]
13. Species and antifungal susceptibility profile of agents causing vulvovaginal candidiasis in a military population: a cross-sectional study.
Trajano DTM; Melhem MSC; Takahashi JPF; Bonfietti LX; de Araújo MR; Corrêa VB; Araújo KBO; Barnabé V; Fernandes CG
Med Mycol; 2023 Mar; 61(3):. PubMed ID: 36893795
[TBL] [Abstract][Full Text] [Related]
14. First report of sporadic cases of Candida auris in Colombia.
Parra-Giraldo CM; Valderrama SL; Cortes-Fraile G; Garzón JR; Ariza BE; Morio F; Linares-Linares MY; Ceballos-Garzón A; de la Hoz A; Hernandez C; Alvarez-Moreno C; Le Pape P
Int J Infect Dis; 2018 Apr; 69():63-67. PubMed ID: 29421668
[TBL] [Abstract][Full Text] [Related]
15. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Differential Pathogenicity of Candida auris in a Galleria mellonella Infection Model.
Garcia-Bustos V; Ruiz-Saurí A; Ruiz-Gaitán A; Sigona-Giangreco IA; Cabañero-Navalon MD; Sabalza-Baztán O; Salavert-Lletí M; Tormo MÁ; Pemán J
Microbiol Spectr; 2021 Sep; 9(1):e0001321. PubMed ID: 34106570
[TBL] [Abstract][Full Text] [Related]
17. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
18. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and Antifungal Susceptibility of Pathogenic Yeasts in China: A 10-Year Retrospective Study in a Teaching Hospital.
Song Y; Chen X; Yan Y; Wan Z; Liu W; Li R
Front Microbiol; 2020; 11():1401. PubMed ID: 32719663
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study.
Wang Q; Cai X; Li Y; Zhao J; Liu Z; Jiang Y; Meng L; Li Y; Pan S; Ai X; Zhang F; Li R; Zheng B; Wan Z; Liu W
Front Microbiol; 2022; 13():1006375. PubMed ID: 36274705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
